TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 DATA MINING PROCESS
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 SECONDARY RESEARCH DATA FLOW:
3.5 PRIMARY RESEARCH:
3.5.1 PRIMARY RESEARCH DATA FLOW:
3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 REVENUE ANALYSIS APPROACH
3.7 DATA FORECASTING
3.7.1 DATA FORECASTING TECHNIQUE
3.8 DATA END USERLING
3.8.1 MICROECONOMIC FACTOR ANALYSIS:
3.8.2 DATA END USERLING:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF DIABETES, OBESITY, AND OTHER CHRONIC DISEASES
4.2.2 RISING AWARENESS OF SELF-ADMINISTRATION
4.2.3 PATIENT PREFERENCE FOR PEN DEVICES
4.3 RESTRAINTS
4.3.1 REGULATORY CHALLENGES
4.4 OPPORTUNITY
4.4.1 TECHNOLOGICAL INNOVATION AND PATIENT-CENTRIC SOLUTIONS
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE EUROPE PEN NEEDLE MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON KEY PLAYERS
5.3.3 IMPACT ON DEMAND AND SUPPLY
6 EUROPE PEN NEEDLES MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 STANDARD PEN NEEDLE
6.3 SAFETY PEN NEEDLE
7 EUROPE PEN NEEDLES MARKET, BY NEEDLE LENGTH
7.1 OVERVIEW
7.2 4MM
7.3 5MM
7.4 6MM
7.5 8MM
7.6 10MM
7.7 12.7MM
8 EUROPE PEN NEEDLE MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 INSULIN THERAPY
8.3 GLP-1 THERAPY
8.4 GROWTH HORMONE THERAPY
8.5 OSTEOPOROSIS
8.6 OTHERS
9 EUROPE PEN NEEDLE MARKET, BY DISTRIBUTION CHANNEL
9.1 OVERVIEW
9.2 DIRECT SALES
9.3 DISTRIBUTORS
10 EUROPE PEN NEEDLE MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS & CLINICS
10.3 HOMECARE SETTINGS
10.4 OTHERS
11 EUROPE PEN NEEDLE MARKET, BY REGION
11.1 OVERVIEW
11.2 EUROPE
11.2.1 FRANCE
11.2.2 REST OF EUROPE
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 MARKET SHARE ANALYSIS, 2022
12.3 COMPETITOR DASHBOARD
12.4 PUBLIC PLAYERS STOCK SUMMARY
12.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
12.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.6.1 PRODUCT LAUNCH/PRODUCT APPROVAL
13 COMPANY PROFILES
13.1 NOVO NORDISK A/S
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 PRODUCTS OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 TERUMO CORPORATION
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 PRODUCTS OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 SWOT ANALYSIS
13.2.6 KEY STRATEGIES
13.3 NIPRO EUROPE GROUP COMPANIES
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 PRODUCTS OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 SWOT ANALYSIS
13.3.6 KEY STRATEGIES
13.4 SHANGHAI BEIPU MEDICAL CO., LTD.
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 PRODUCTS OFFERED
13.4.4 KEY DEVELOPMENTS
13.4.5 KEY STRATEGIES
13.5 PROMISEMED MEDICAL DEVICES INC.
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 PRODUCTS OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 KEY STRATEGIES
13.6 TAECHANG INDUSTRIAL CO., LTD.
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 PRODUCTS OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 KEY STRATEGIES
13.7 VITREX MEDICAL A/S
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 PRODUCTS OFFERED
13.7.4 KEY DEVELOPMENTS
13.7.5 KEY STRATEGIES
13.8 EMBECTA CORP.
13.8.1 COMPANY OVERVIEW
13.8.2 FINANCIAL OVERVIEW
13.8.3 PRODUCTS OFFERED
13.8.4 KEY DEVELOPMENTS
13.8.5 SWOT ANALYSIS
13.8.6 KEY STRATEGY
13.9 YPSOMED HOLDING AG
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 PRODUCTS OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 SWOT ANALYSIS
13.9.6 KEY STRATEGY
13.10 MTD MEDICAL TECHNOLOGY AND DEVICES
13.10.1 COMPANY OVERVIEW
13.10.2 FINANCIAL OVERVIEW
13.10.3 PRODUCTS OFFERED
13.10.4 KEY DEVELOPMENTS
13.10.5 KEY STRATEGIES
13.11 OWEN MUNFORD
13.11.1 COMPANY OVERVIEW
13.11.2 FINANCIAL OVERVIEW
13.11.3 PRODUCTS OFFERED
13.11.4 KEY DEVELOPMENTS
13.11.5 KEY STRATEGIES
